DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Eagle Pharmaceuticals, Inc. (EGRX)
« Back to company indexEGRX Chatter Timeline
Stock Ticker for EGRX
Most Active Tweeters for EGRX
| User | Tweets |
|---|---|
| @AmericanBanking | 5 |
| @WKRBNews | 2 |
| @StockTexts | 2 |
| @macondailynews | 2 |
| @ZolmaxNews | 2 |
Recent Tweets for EGRX
 |
@SeekingAlpha $EGRX - Eagle Pharmaceuticals (EGRX) Presents At RBC Capital Markets 2019 Healthcare Conference - Slideshow https://t.co/3Gmr3QXC6f May 23rd 2019, 2:05pm |
 |
@StockTexts $EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/a9Y1bw3Evt May 22nd 2019, 7:05am |
 |
@omahacharts Long $EGRX here and now: https://t.co/tWMVdxp1Fe May 21st 2019, 9:05am |
 |
@bulletin_en Eagle Pharmaceuticals $EGRX Valuation Declined While Dupont Capital Management Has Raised Position by $507,800; Ame… https://t.co/MzVzxM9vwy May 21st 2019, 8:05am |
 |
@macondailynews Analysts Anticipate Eagle Pharmaceuticals Inc $EGRX to Announce $0.72 EPS https://t.co/8xd7KSPsDe May 18th 2019, 11:05am |
 |
@SwingTradeBot 200 DMA Support today: $EGRX $NTWK ... https://t.co/LjP7KUcNnp May 17th 2019, 3:05pm |
 |
@ZolmaxNews Eagle Pharmaceuticals $EGRX Upgraded at Zacks Investment Research https://t.co/gq2Q3zf37D May 17th 2019, 12:05pm |
 |
@WKRBNews Eagle Pharmaceuticals $EGRX Upgraded at Zacks Investment Research https://t.co/VTSR9U5RQf #markets May 17th 2019, 12:05pm |
 |
@AmericanBanking Zacks: Analysts Expect Eagle Pharmaceuticals Inc $EGRX Will Announce Quarterly Sales of $51.33 Million https://t.co/JSi42AsmIW #stocks May 17th 2019, 1:05am |
|
@macondailynews $51.33 Million in Sales Expected for Eagle Pharmaceuticals Inc $EGRX This Quarter https://t.co/ruOqGlq2Gj May 17th 2019, 1:05am |
 |
@WatchlistN Eagle Pharmaceuticals $EGRX Upgraded to “Hold” by Zacks Investment Research https://t.co/vpBvCz60yh May 16th 2019, 11:05am |
 |
@1stOncology #EaglePharmaceuticals, Inc. to Present at 2019 RBC Capital Markets Global #HealthcareConference $EGRX https://t.co/S3strwVWXe May 16th 2019, 9:05am |
|
@AmericanBanking Brokerages Anticipate Eagle Pharmaceuticals Inc $EGRX to Post $0.72 Earnings Per Share https://t.co/gY4VUcFMtm #stocks May 15th 2019, 6:05pm |
 |
@ProTradersNews $EGRX: Eagle Pharmaceuticals, Inc. to Present at 2019 RBC Capital Markets …: https://t.co/rjx2u6qk8X May 15th 2019, 4:05pm |
|
@SwingTradeBot 200 DMA Support today: $EGRX ... https://t.co/LjP7KUcNnp May 15th 2019, 1:05pm |
 |
@stocknewstimes Eagle Pharmaceuticals $EGRX Lifted to Hold at Zacks Investment Research https://t.co/a1vxljWYO2 May 14th 2019, 9:05am |
 |
@SleekMoneycom Eagle Pharmaceuticals $EGRX Lifted to Hold at Zacks Investment Research https://t.co/sUet4qvzMe #investing May 14th 2019, 9:05am |
 |
@fintel_io Hudson Executive Capital LP has filed an amended 13D/A, reporting 6.0% ownership in $EGRX - https://t.co/BaYZq4BjV0 May 14th 2019, 7:05am |
 |
@Stock_News_Now $EGRX: New SEC Filing for EGRX: Form SC 13D/A (No. 0000914121-19-001251): https://t.co/WfgMvbKfKO May 14th 2019, 7:05am |
 |
@whalewisdom New SC 13D/A from HUDSON EXECUTIVE CAPITAL LP concerning $EGRX. See details at https://t.co/Uw7sLl5fR4 May 14th 2019, 6:05am |
 |
@ResearchPool $EGRX #EAGLE PHARMACEUTICALS 1 director sold: A director at Eagle Pharmaceuticals Inc sold 159,223 shares at 56.813… https://t.co/TD5DJXDTH9 May 14th 2019, 6:05am |
|
@WKRBNews Insider Selling: Eagle Pharmaceuticals Inc $EGRX Director Sells 159,223 Shares of Stock https://t.co/UCtANvpqNd #markets May 14th 2019, 4:05am |
|
@stocknewstimes Q2 2019 Earnings Forecast for Eagle Pharmaceuticals Inc Issued By William Blair $EGRX https://t.co/UDPPNnHaV3 May 14th 2019, 2:05am |
|
@SleekMoneycom Q2 2019 Earnings Forecast for Eagle Pharmaceuticals Inc Issued By William Blair $EGRX https://t.co/fj04wfMRt8 #investing May 14th 2019, 2:05am |
|
@AmericanBanking Eagle Pharmaceuticals Inc $EGRX Director Douglas L. Braunstein Sells 159,223 Shares https://t.co/LZKQQJ28YR #stocks May 13th 2019, 8:05pm |
|
@ZolmaxNews Douglas L. Braunstein Sells 159,223 Shares of Eagle Pharmaceuticals Inc $EGRX Stock https://t.co/EItLBPg89m May 13th 2019, 8:05pm |
 |
@InsiderAlertsIA $EGRX: New Insider Filing on Director DOUGLAS L BRAUNSTEIN: https://t.co/VqET6Kw3sY May 13th 2019, 6:05pm |
|
@StockTexts $EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/ZwNMrXsqqo May 13th 2019, 5:05pm |
 |
@RTFilingsStocks Braunstein Douglas L files Form 4 for $EGRX Sold 159223 shares Price range: $56.14-57.95 Transaction Dates: 5/9/201… https://t.co/3dxskxOVpq May 13th 2019, 5:05pm |
|
@AmericanBanking Q2 2019 EPS Estimates for Eagle Pharmaceuticals Inc Lowered by William Blair $EGRX https://t.co/fIwU2SXKnv #stocks May 13th 2019, 2:05am |
 |
@dailypoliticaln Q2 2019 EPS Estimates for Eagle Pharmaceuticals Inc Lowered by William Blair $EGRX https://t.co/kdfCenmbyu May 13th 2019, 2:05am |
 |
@ConsumerFeed Eagle Pharmaceuticals Inc $EGRX Shares Bought by PNC Financial Services Group Inc. https://t.co/B7Zw2RRnh1 May 12th 2019, 3:05am |
 |
@bbnsnews Eagle Pharmaceuticals’ $EGRX “Hold” Rating Reaffirmed at Cantor Fitzgerald https://t.co/7AlsNk0Lgx May 11th 2019, 12:05pm |
 |
@CSIMarket $EGRX #stock #StockMarket #EaglePharmaceuticals issued on https://t.co/savSNU1XbB EGRX had impressive forth quarte… https://t.co/DnJGqmMgID May 11th 2019, 3:05am |
|
@AmericanBanking Eagle Pharmaceuticals $EGRX – Research Analysts’ Recent Ratings Changes https://t.co/YOcW1RUGg7 #stocks May 10th 2019, 4:05am |
 |
@newswithvalue $EGRX $PZN: Hedge Funds Have Never Been More Bullish On Eagle …: https://t.co/tVMRJb9USD May 9th 2019, 9:05pm |
 |
@TickerReport Eagle Pharmaceuticals Inc $EGRX Receives $69.40 Consensus Price Target from Analysts https://t.co/UFQ9Gtz3L4 May 9th 2019, 1:05pm |
 |
@ChartMill $EGRX: Comparing the growth rate of the last 5 years to the rate of the upcoming 2 years, we see that the growt ...… https://t.co/yylf43DGUo May 9th 2019, 1:05pm |
|
@dailypoliticaln Eagle Pharmaceuticals $EGRX Given “Hold” Rating at Cantor Fitzgerald https://t.co/VzdEHTibha May 9th 2019, 7:05am |
 |
@the_chart_life $EGRX Eagle Pharma ..."Focuses on developing and commercializing injectable products primarily in the critical care… https://t.co/Vk8KmKVe59 May 8th 2019, 9:05pm |
 |
@ThisLincolnian Eagle Pharmaceuticals $EGRX Receives “Hold” Rating from Cantor Fitzgerald https://t.co/IsTWfc5K79 May 8th 2019, 10:05am |
|
@TickerReport Eagle Pharmaceuticals $EGRX Announces Quarterly Earnings Results https://t.co/7cjlyqyh7n May 8th 2019, 10:05am |
|
@StockTexts $EGRX Eagle Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/UOvPAiViPz May 8th 2019, 7:05am |
 |
@TheMarketsDaily Eagle Pharmaceuticals $EGRX Announces Earnings Results https://t.co/RchRCqGLma May 7th 2019, 3:05pm |
|
@AmericanBanking Eagle Pharmaceuticals $EGRX Announces Quarterly Earnings Results https://t.co/5m0Kut8yI2 #stocks May 7th 2019, 2:05pm |
 |
@SiteFocusHQ $EGRX Qualitative Analysis of recent earnings identified Eagle Pharmaceuticals Inc (NASDAQ: EGRX ) business focus o… https://t.co/vQSJXDAUt1 May 7th 2019, 2:05pm |
 |
@NewsToDesk $EGRX: Eagle Pharmaceuticals’ (EGRX) CEO Scott Tarriff on Q1 2019 …: https://t.co/HZ7CQSzBG4 May 7th 2019, 2:05pm |
|
@SeekingAlpha $EGRX - Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2019 Results - Earnings Call Transcript https://t.co/JhRawtrYqq May 7th 2019, 2:05pm |
 |
@StockNewsWires $EGRX: Eagle Pharmaceuticals Inc (EGRX) Q1 2019 Earnings Call Transcript: https://t.co/yoyeaRrLLg May 7th 2019, 12:05pm |
 |
@EarningsAlley Summary for the Eagle Pharmaceuticals, Inc. earnings call. $EGRX #earnings #EaglePharmaceuticalsInc https://t.co/RTLYR2toQf May 7th 2019, 12:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.